fbpx
Treating Brain Tumors with CyberKnife Technology

 

More than any other cancer or condition, brain tumors can have lasting and life-altering physical, cognitive, and psychological impacts on a patient’s life.  It is important to find the treatment that is right for you and will treat the tumor while minimizing radiation exposure to surrounding healthy tissue. The CyberKnife® Robotic Radiosurgery System is a […]

 

Learn More

 

 

National Brain Tumor Awareness Month

 

May is National Brain Tumor Awareness Month.  Driven by advancement in research, surgical techniques, genetic discoveries, and much more, it has never been a better time to take action on brain tumors. The National Brain Tumor Society (NBTS), an organization whose mission is to unrelentingly invest in, mobilize, and unite our community to discover a […]

 

Learn More

 

 

Treating Metastatic Brain Tumors with CyberKnife Technology

 

Lung cancer often spreads to the brain.  About 10 percent of patients with non-small cell lung cancer (NSCLC) have brain metastases at their initial diagnosis and as many as 40 percent will eventually develop metastatic brain tumors at some stage during their illness. Vivian Wilson was part of that 40 percent.  The 57-year-old Kentucky resident […]

 

Learn More

 

 

Shiao Woo, M.D. Named President of the MD Anderson Radiation Oncology Gilbert H. Fletcher Society

 

Shiao Woo, M.D., M.B.B.S, F.A.C.R., Medical Director at Louisville CyberKnife, was recently named president of the MD Anderson Radiation Oncology Gilbert H. Fletcher Society. The MD Anderson Radiation Oncology Gilbert H. Fletcher Society honors Dr. Gilbert H. Fletcher, a radiation oncologist recognized for his contributions to the field of radiation oncology.  The society was established […]

 

Learn More

 

 

Dr. Dragun and Dr. Gurka Talk about CyberKnife as an Alternative to Surgery on WHAS-TV’s Great Day Live

 

Research Shows Metastatic Brain Tumor Patients Under 50 Have Improved Survival Rates with Stereotactic Radiosurgery Data from a study recently published in the International Journal of Radiation Oncology indicates that patients under 50 with limited metastatic brain tumors should receive stereotactic radiosurgery (SRS) without whole-brain radiation therapy (WBRT) for chances of improved survival. Researchers analyzed […]

 

Learn More

 

 

National Women’s Health Week: 2015 ACS Women’s Cancer Statistics

 

May 10-16 is National Women’s Health Week, a time to empower women of all ages to make their health a priority and to increase efforts to educate women on ways to improve their health. In recognition of this national health observation, we’re highlighting a few 2015 women’s cancer facts from the American Cancer Society below: […]

 

Learn More

 

 

Brain Tumor Awareness Month: The Role of Stereotactic Radiosurgery

 

May marks the observance of National Brain Tumor Awareness Month. Louisville CyberKnife joins these efforts to raise awareness of brain tumors and treatment options. Brain tumors can be treated with surgery, radiation therapy, chemotherapy or a combination of these therapies. Radiation therapy and chemotherapy are used widely as secondary treatment following surgery, and both therapies […]

 

Learn More

 

 

Presentation: CyberKnife Treatment for Brain Tumors

 

If you or a loved one is considering CyberKnife® treatment for a brain tumor diagnosis, the presentation below includes useful information about the disease and CyberKnife technology that you may find helpful as you make your treatment decision. For more information about how Louisville CyberKnife treats benign and malignant brain tumors with CyberKnife, contact our center […]

 

Learn More

 

 

New Research Supports CyberKnife for Neurological Disease Treatment

 

Two studies recently presented at the annual meeting of the European Association of Neurosurgical Societies (EANS) reinforced the benefits of stereotactic radiosurgery (SRS) for neurological diseases, using the CyberKnife® system. Dr. Alfredo Conti from the University Hospital of Messina in Italy used CyberKnife in one study to treat perioptic meningioma, a type of benign tumor […]

 

Learn More

 

 

CyberKnife Treatment Overview: SRS for Glioblastomas

 

Glioblastomas are a type of brain tumor that can develop from astrocytes, cells that make up the supportive tissue of the brain. Usually highly malignant, glioblastomas can reproduce quickly and invade and live within normal brain tissue. Treatment options for glioblastomas can include surgery, chemotherapy and radiation therapy. Louisville CyberKnife treats glioblastomas and other brain tumors […]

 

Learn More